• Viking Therapeutics average return on tangible equity for 2023 was -36.44, a 7.59% decline from 2022.
• Viking Therapeutics average return on tangible equity for 2022 was -33.87, a 57.98% increase from 2021.
• Viking Therapeutics average return on tangible equity for 2021 was -21.44, a 63.79% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.